Sisram Medical Dirección
Dirección controles de criterios 2/4
Sisram Medical's CEO is Lior Dayan, appointed in Jun 2017, has a tenure of 7.42 years. total yearly compensation is $1.53M, comprised of 56.6% salary and 43.4% bonuses, including company stock and options. directly owns 0.2% of the company’s shares, worth HK$3.34M. The average tenure of the management team and the board of directors is 1.8 years and 7.3 years respectively.
Información clave
Lior Dayan
Chief Executive Officer (CEO)
US$1.5m
Compensación total
| Porcentaje del salario del CEO | 56.6% |
| Permanencia del CEO | 7.4yrs |
| Participación del CEO | 0.2% |
| Permanencia media de la dirección | 1.8yrs |
| Promedio de permanencia en la Junta Directiva | 7.3yrs |
Actualizaciones recientes de la dirección
Recent updates
What Sisram Medical Ltd's (HKG:1696) 40% Share Price Gain Is Not Telling You
Oct 07
Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?
Aug 23Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet
Jul 24Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)
Jun 17Returns On Capital At Sisram Medical (HKG:1696) Have Stalled
Apr 21Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?
Mar 28Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)
Mar 05Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)
Jan 23Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?
Dec 29Is Sisram Medical (HKG:1696) Using Too Much Debt?
Nov 09Returns On Capital At Sisram Medical (HKG:1696) Have Stalled
Oct 19At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?
Sep 18Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year
Aug 14Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?
Jun 16Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue
May 30Is Sisram Medical (HKG:1696) Using Too Much Debt?
Apr 19Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?
Mar 01Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital
Jan 12Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet
Dec 21Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?
Dec 01Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital
Oct 14Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching
Sep 28These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely
Aug 25Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?
Aug 01These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely
May 19Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?
May 03If You Like EPS Growth Then Check Out Sisram Medical (HKG:1696) Before It's Too Late
Apr 11Sisram Medical (HKG:1696) Is Experiencing Growth In Returns On Capital
Mar 17Is Now An Opportune Moment To Examine Sisram Medical Ltd (HKG:1696)?
Nov 22Calculating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)
Aug 22Be Wary Of Sisram Medical (HKG:1696) And Its Returns On Capital
Jul 27Here's Why We Think Sisram Medical Ltd's (HKG:1696) CEO Compensation Looks Fair
Jun 24Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$24m |
| Mar 31 2024 | n/a | n/a | US$28m |
| Dec 31 2023 | US$2m | US$863k | US$31m |
| Sep 30 2023 | n/a | n/a | US$35m |
| Jun 30 2023 | n/a | n/a | US$38m |
| Mar 31 2023 | n/a | n/a | US$39m |
| Dec 31 2022 | US$3m | US$1m | US$40m |
| Sep 30 2022 | n/a | n/a | US$38m |
| Jun 30 2022 | n/a | n/a | US$35m |
| Mar 31 2022 | n/a | n/a | US$33m |
| Dec 31 2021 | US$2m | US$767k | US$31m |
| Sep 30 2021 | n/a | n/a | US$28m |
| Jun 30 2021 | n/a | n/a | US$24m |
| Mar 31 2021 | n/a | n/a | US$19m |
| Dec 31 2020 | US$769k | US$596k | US$13m |
| Sep 30 2020 | n/a | n/a | US$13m |
| Jun 30 2020 | n/a | n/a | US$13m |
| Mar 31 2020 | n/a | n/a | US$17m |
| Dec 31 2019 | US$759k | US$606k | US$21m |
| Sep 30 2019 | n/a | n/a | US$22m |
| Jun 30 2019 | n/a | n/a | US$24m |
| Mar 31 2019 | n/a | n/a | US$23m |
| Dec 31 2018 | US$884k | US$560k | US$22m |
| Sep 30 2018 | n/a | n/a | US$18m |
| Jun 30 2018 | n/a | n/a | US$14m |
| Mar 31 2018 | n/a | n/a | US$12m |
| Dec 31 2017 | US$829k | US$361k | US$11m |
Compensación vs. Mercado: Lior's total compensation ($USD1.53M) is above average for companies of similar size in the Hong Kong market ($USD359.95K).
Compensación vs. Ingresos: Lior's compensation has been consistent with company performance over the past year.
CEO
Lior Dayan (54 yo)
7.4yrs
Permanencia
US$1,526,000
Compensación
Mr. Lior Moshe Dayan has been Chief Executive Officer and Executive Director at Sisram Medical Ltd since June 6, 2017 and its President since 2023 and is responsible for its overall and day-to-day manageme...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman | 8.6yrs | US$27.00k | 0.053% HK$ 865.0k | |
| President | 7.4yrs | US$1.53m | 0.20% HK$ 3.2m | |
| Chief Financial Officer | less than a year | sin datos | sin datos | |
| Chief Operating Officer | 6.6yrs | sin datos | sin datos | |
| VP of Finance | 1.8yrs | sin datos | sin datos | |
| Chief Information Officer | less than a year | sin datos | sin datos | |
| Chief Marketing Officer | 1.8yrs | sin datos | sin datos | |
| Chief People Officer | 1.8yrs | sin datos | sin datos | |
| President of ROW | 1.8yrs | sin datos | sin datos | |
| EVP of R&D | 1.8yrs | sin datos | sin datos | |
| President NA | 1.8yrs | sin datos | sin datos | |
| Company Secretary | 2.8yrs | sin datos | sin datos |
1.8yrs
Permanencia media
51.5yo
Promedio de edad
Equipo directivo experimentado: 1696's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman | 8.6yrs | US$27.00k | 0.053% HK$ 865.0k | |
| President | 7.4yrs | US$1.53m | 0.20% HK$ 3.2m | |
| Independent Non-Executive Director | 7.3yrs | US$32.00k | sin datos | |
| Non-Executive Director | 8.1yrs | sin datos | sin datos | |
| Independent Non-Executive Director | 7.3yrs | US$32.00k | sin datos | |
| Independent Non-Executive Director | 7.3yrs | US$32.00k | sin datos | |
| Independent Non-Executive Director | 7.3yrs | US$32.00k | sin datos | |
| Non-Executive Director | 4.3yrs | sin datos | sin datos |
7.3yrs
Permanencia media
51.5yo
Promedio de edad
Junta con experiencia: 1696's board of directors are considered experienced (7.3 years average tenure).